[215 Pages Report] The global positive air pressure devices market size reached US$ 2.3 Billion in 2021 and is expected to enjoy a valuation of US$ 2.5 Billion by the end of 2022. Furthermore, with rising usage for treating medical conditions like sleep apnea and respiratory failures, the overall demand for positive air pressure devices is poised to grow at a CAGR of 6.4% between 2022 and 2032, surpassing a market valuation of US$ 4.7 Billion by 2032.
Based on product, the continuous positive airways pressure devices (CPAP) segment dominated the global positive air pressure devices market with a share of about 71.4% in 2021 and it is likely to retain its dominance even during the forecast period.
| Attribute | Key Statistics |
|---|---|
| Positive Air Pressure Devices Market Base Value (2021) | US$ 2.3 Billion |
| Estimated Market Value (2022) | US$ 2.5 Billion |
| Projected Market Value (2032) | US$ 4.7 Billion |
| Value-based CAGR (2022 to 2032) | 6.4% |
| Market Share of Top 5 Countries | 55.5% |
A mechanical ventilator is a device that assists a patient in breathing (ventilating) during surgery or when they are unable to do so due to a serious disease. Until patients recover enough to no longer require it, a mechanical ventilator is used to reduce the work of breathing. The device guarantees that the body gets enough oxygen and that carbon dioxide is expelled. When some conditions or airway obstructions make it impossible to breathe normally, the usage of mechanical ventilation devices like positive air pressure devices becomes necessary.
A machine is used in positive airway pressure (PAP) treatment to drive air into the lungs' airways under pressure. This keeps the upper airway open while you're sleeping. People with sleep apnea and other breathing difficulties are protected against bouts of airway collapse by the forceful air given by continuous positive airway pressure.
The main elements that support the use of mechanical ventilators include technological breakthroughs such as significant advancement in the field of positive airway pressure (PAP) systems and improvements in the battery life of transportation and portable devices.
Similarly, the rising prevalence of sleep apnea and other breathing disorders across the globe is expected to act as a catalyst triggering growth in the global positive air pressure devices market during the forecast period.
Positive air pressure devices are being extensively used in the treatment of sleep apnea, critically ill patients in hospitals with respiratory failure, and newborn infants, and for the prevention and treatment of atelectasis in patients with difficulty taking deep breaths.
The overall positive air pressure devices market formed approximately 42.1% value share of the global mechanical ventilation market which stood at ~US$ 5.6 Billion in 2021.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of positive air pressure devices are poised to grow at 6.4% CAGR between 2022 and 2032, in comparison to the 5.7% CAGR registered during the historical period from 2012 to 2021. Increasing demand for positive air pressure devices due to the rising prevalence of sleep disorders and breathing failures including obstructive sleep apnea and COPD is a key factor driving the global market.
The positive airway pressure (PAP) devices market is expanding primarily due to the steadily rising number of patients with obesity, respiratory illnesses, and sleep difficulties. There is significant data, especially from demographics in Western nations, that suggests that average sleep length is declining and that insomnia and other sleep disruptions are becoming more and more common.
Insomnia affects more than 20% of adults overall in Canada and the USA, according to data from National Surveys, and it is predicted that this percentage will rise over the coming decades. These percentages are in line with the prevalence rates of short sleep duration revealed in population-based research conducted over the previous three decades in several Western countries.
Similarly, according to the National Library of Medicine, obstructive sleep apnea affects around 1 billion persons worldwide. This is acting as a catalyst triggering the growth of the global positive air pressure devices market.
In addition to this, the growing popularity of home healthcare and increasing health awareness will create lucrative growth opportunities for positive air pressure device manufacturers during the assessment period.
Rising Prevalence of Sleep Disorders and Respiratory Diseases to foster Growth of Positive Air Pressure Devices Market
The global positive air pressure devices market is anticipated to grow at a healthy pace during the projected period, owing to the rising prevalence of various sleep disorders and respiratory diseases across the world.
Chronic obstructive pulmonary disease (COPD), which claimed 3.23 million lives in 2019, is the third most common cause of death globally, according to the World Health Organization. In low- and middle-income nations, COPD fatalities in people under 70 years of age account for about 90% of all mortality.
According to the National Center for Biotechnology Information, undertaking positive airway pressure therapy was linked to a decrease in hospitalization among patients with chronic obstructive pulmonary disease. Thus, the growing usage of positive airway pressure therapy for treating patients suffering from COPD will continue to boost sales of positive air pressure devices in the market.
Similarly, numerous studies conducted around the world have revealed that 10%-30% of people suffer from insomnia, with some estimates reaching 50%-60%. Reduced social functioning and a lower quality of life, neurocognitive impairment, an elevated incidence of traffic accidents, cerebral, cardiac, and metabolic morbidity, as well as a higher death rate, are all long-term effects of Obstructive sleep apnea syndrome.
The use of continuous positive airway pressure (CPAP) therapy for middle-aged individuals with moderate to severe OSA syndrome has been proven to be both effective and affordable. The prevalence of apnea syndrome is higher in older adults (over 60), and the effects can be confused with the functional decline associated with aging. Therefore, correcting the OSA syndrome element of any functional impairment should boost independence and lower healthcare expenses in aging populations.
Most people with obstructive sleep apnea continue to receive treatment with positive airway pressure (PAP). For patients with uncomplicated OSA sleep disorders, CPAP, APAP, and BPAP are all acceptable treatments that can be utilized across the severity continuum of the condition. Driven by this, demand for positive air pressure devices is likely to rise at a strong pace over the next ten years.
Also, the constant introduction of new features created to adapt to the requirements of diverse patients is supposed to drive the market for positive air pressure devices in the forecast period.
Principal Consultant
There are some side effects of CPAP treatment, such as congestion, runny nose, and dry mouth; humidification can frequently help with these symptoms. Many patients initially find the mask inconvenient, claustrophobic, or embarrassing. Masks have the potential to irritate or cause the skin to become red.
Even though CPAP therapy has several advantages, compliance is still a significant issue both in the inpatient and outpatient settings.
Since these devices are also available on an online and at-home basis, a decrease in diagnostic and therapeutic procedures at sleep clinics can directly impact the number of sleep apnea tests, which can limit the development of a positive air pressure equipment market.
Also, these operations may have a major impact on the transmission rate of diseases, which can delay elective procedures, disrupt the supply chain for services, and can limit the ability of healthcare facilities to generate income.
Increasing Incidence of Sleep Apnea Pushing Demand in the USA
As per FMI, the USA will continue to dominate the global positive air pressure devices market during the forecast period, accounting for the largest market share of around 24.8% in 2022. Growth in the USA positive air pressure devices market is driven by the rising prevalence of sleep apnea and breathing disorders, high levels of healthcare awareness among people, and the growing popularity of home healthcare.
Similarly, the presence of leading medical device manufacturers, favorable reimbursement policies, and increased demand for positive air pressure machines are expected to boost the market in the country during the forecast period.
Over the years, there has been a sharp rise in the cases of sleep apnea across the USA which has generated enormous demand for medical devices like positive air pressure devices and the trend is likely to continue during the forecast period. For instance, as per the American Sleep Apnea Foundation, around 25 million Americans suffer from sleep apnea and the number is expected to further rise during the upcoming years.
Availability of Advanced Products Driving Market in Germany
Germany is estimated to hold a market share of 8.1% in the global positive air pressure devices market in 2022 and is further expected to grow at a healthy pace during the next ten years. Growth in the positive air pressure devices market in Germany is expanding as a result of well-defined regulatory rules and rising investments in research and development for new devices.
Similarly, the increasing prevalence of respiratory failures, flourishing medical tourism, and easy availability of advanced portable mechanical ventilation devices are expected to boost the market in the country during the forecast period.
Growing Adoption of Positive Air Pressure Devices in Home Care Settings Boosting Market in China
China will contribute nearly 8.0% revenue share to the global positive air pressure devices market in 2022, making it one of the leading markets across East Asia.
The high prevalence of long-term sleep problems and rising patient awareness are expected to increase the demand for Positive air pressure devices in China, which will in turn fuel the expansion of the local market.
Additionally, home care settings are expanding quickly due to the region's high prevalence and frequency of long-term respiratory disorders and the utilization of the equipment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Continuous Positive Airway Pressure Devices Remain Highly Sought-After Products
As per FMI, continuous positive airways pressure devices (CPAP) will continue to dominate the global positive air pressure devices market, accounting for the highest market share of 70.7% in 2022. This can be attributed to the rising adoption of these devices across various end-user sectors.
Continuous positive airway pressure (CPAP) devices have become the gold standard treatment for obstructive sleep apnea. These continuous positive airway pressure devices provide a constant level of pressure greater than atmospheric pressure to the upper respiratory tract of a person.
However, the bi-level positive airway pressure (BiPAP)/ variable positive airway pressure (VPAP) segment will grow at a higher CAGR of about 9.9% during the forecast period. This is because post-COVID-19 pandemic, these devices are increasing in their demand due to their easy portability and use in the product's market.
Obstructive Sleep Apnea Segment to Generate Highest Revenue Share
As per FMI, the obstructive sleep apnea segment is estimated to dominate the global positive air pressure devices market with a revenue share of around 64.5% in 2022 and is further expected to display a growth rate of 5.9% over the forecast period.
The growth of this segment can be attributed to the rising prevalence of obstructive sleep apnea worldwide and the increasing adoption of positive air pressure devices for treating this medical condition.
However, amid the rising incidence of chronic respiratory failure, the respiratory failures segment is likely to grow at the highest CAGR of about 7.5% during the forecast period of 2022 and 2032.
The usage of Positive Air Pressure Remains High in Hospitals
Based on end users, the hospital segment will hold the highest market share value of 57.9% in 2022. This is because most of these devices had been used under a hospital setup only. Similarly, the rising number of hospitals and the growing preference of patients to opt for treatments at hospitals will further accelerate the growth of this segment.
However, with the growing popularity of home healthcare and the availability of portable devices, the home care settings segment is expected to grow at the fastest CAGR of about 8.6% during the forecast period.
With several competitors in the positive air pressure device manufacturing sphere, the overall market is highly fragmented. To meet consumer demand and expand their customer base, leading companies are implementing strategic approaches such as mergers and acquisitions, partnerships and collaborations, and new product launches.
Instances of key developmental strategies by the industry players in the positive air pressure devices market are given below:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | US$ 2.5 Billion |
| Projected Market Size (2032) | US$ 4.7 Billion |
| Anticipated Growth Rate (2022 to 2032) | 6.4% |
| Forecast Period | 2012 to 2021 |
| Historical Data Available for | 2022 to 2032 |
| Market Analysis | US$ Million for Value and Absolute Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa |
| Key Market Segments Covered | Product, Application End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The global positive air pressure devices market is expected to reach US$ 2.5 Billion in 2022.
As per FMI, the global sales of positive air pressure devices are projected to grow at 6.4% CAGR between 2022 and 2032, totaling a market valuation of US$ 4.7 Billion by the end of 2032.
Technological advancements in mechanical ventilation, more investments in R&D in the healthcare sector, and increasing geriatric population with the rising incidence of sleep disorders are some of the key trends shaping growth in the positive air pressure devices market.
The USA, China, Japan, Germany, and the UK are the top countries driving demand for positive air pressure devices.
The USA is estimated to account for about 83.8% of North American positive air pressure devices in 2022.
Demand for positive air pressure devices in South Asia is expected to register a growth of 9.6% over the next ten years.
The overall positive air pressure devices market in Europe is expected to expand at 5.8% CAGR during the forecast period.
China, Japan, and the USA are the key producers of positive air pressure devices.
Some of the key players operating in positive air pressure devices market include 3B Medical, Inc, Hamilton Medical AG, BMC Medical Co. Ltd, Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited, Hebei Topson Medical Technology Co., Ltd., Kare Medical and Analytical Devices Ltd. Co, Koninklijke Philips N.V, Lowenstein Medical Technology GmbH., Narang Medical Limited., Somnetics International, Inc., Draegerwerk AG & Co. K
1. Executive Summary | Positive Air Pressure Devices Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development and Innovation Trends
4. Key Success Factors
4.1. Product USPs/features
4.2. Product Adoption Analysis by Region
4.3. Regulatory Landscape
4.4. Reimbursement Scenario
4.5. Key Promotional Strategies
4.6. Technology Assessment
4.7. PORTER Analysis
4.8. PESTLE Analysis
4.9. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Mechanical Ventilator Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Global Increase in Healthcare Expenditure
5.2.2. Global increase in Research and Development expenditure in Biotechnology
5.2.3. Rising Incidences of Sleep Disorders
5.2.4. Adoption of At-Home Devices
5.2.5. Increasing Geriatric Population
5.2.6. Increase in Risk of Cardiovascular Disorders
5.2.7. Increasing Prevalence of Sleep Apnea
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application Type
6.1.3. By End User
6.1.4. By Country
7. Global Market Demand (in Volume) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Units) Analysis, 2012 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Region-wise Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ (Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2012 to 2021
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2022 to 2032
10.3.1. Continuous Positive Airways Pressure Devices (CPAP)
10.3.2. Bi-level Positive Airway Pressure (BiPAP)/ Variable Positive Airway Pressure (VPAP)
10.3.3. Automatic Positive Airway Pressure Devices (APAP)
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application Type
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Application Type, 2012 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis By Application Type, 2022 to 2032
11.3.1. Obstructive sleep apnea
11.3.2. Respiratory failures
11.3.3. Others
11.4. Market Attractiveness Analysis By Application Type
12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis By End User, 2022 to 2032
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Sleep Centers
12.3.4. Home care settings
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2021
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis By Region, 2022 to 2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy 2022 to 2032
14.3.1. By Country
14.3.1.1. United States of America
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application Type
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application Type
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. USA Market Analysis
14.8.1.1. .Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application Type
14.8.1.2.3. By End User
14.8.2. Canada Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application Type
14.8.2.2.3. By End User
15. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application Type
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application Type
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. Mexico Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application Type
15.8.1.2.3. By End User
15.8.2. Brazil Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application Type
15.8.2.2.3. By End User
15.8.3. Argentina Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application Type
15.8.3.2.3. By End User
16. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. United Kingdom
16.3.1.5. Spain
16.3.1.6. Benelux
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Application Type
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application Type
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. Germany Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application Type
16.8.1.2.3. By End User
16.8.2. Italy Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application Type
16.8.2.2.3. By End User
16.8.3. France Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application Type
16.8.3.2.3. By End User
16.8.4. UK Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application Type
16.8.4.2.3. By End User
16.8.5. Spain Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Application Type
16.8.5.2.3. By End User
16.8.6. Benelux Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Application Type
16.8.6.2.3. By End User
16.8.7. Russia Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Application Type
16.8.7.2.3. By End User
17. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Application Type
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application Type
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. India Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application Type
17.8.1.2.3. By End User
17.8.2. Indonesia Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application Type
17.8.2.2.3. By End User
17.8.3. Malaysia Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application Type
17.8.3.2.3. By End User
17.8.4. Thailand Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Application Type
17.8.4.2.3. By End User
18. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2021
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Application Type
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application Type
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. China Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application Type
18.8.1.2.3. By End User
18.8.2. Japan Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application Type
18.8.2.2.3. By End User
18.8.3. South Korea Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application Type
18.8.3.2.3. By End User
19. Oceania Market 2012 to 2021 and Forecast 2022 to 2032
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2021
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2022 to 2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Application Type
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application Type
19.4.4. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country-Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Application Type
19.8.1.2.3. By End User
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Application Type
19.8.2.2.3. By End User
20. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2021
20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2022 to 2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. South Africa
20.3.1.3. Turkey
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Application Type
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Application Type
20.4.4. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country-Level Analysis & Forecast
20.8.1. GCC Countries Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Application Type
20.8.1.2.3. By End User
20.8.2. Turkey Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Application Type
20.8.2.2.3. By End User
20.8.3. South Africa Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Application Type
20.8.3.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. By Regional footprint of Players
21.3.2. Product footprint by Players
21.3.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive (Tentative List)
22.3.1. 3B Medical, Inc
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials
22.3.1.4. SWOT Analysis
22.3.1.5. Sales Footprint
22.3.1.6. Key developments
22.3.1.7. Strategy Overview
22.3.1.7.1. Marketing Strategies
22.3.1.7.2. Channel Strategies
22.3.2. Hamilton Medical AG
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials
22.3.2.4. SWOT Analysis
22.3.2.5. Sales Footprint
22.3.2.6. Key developments
22.3.2.7. Strategy Overview
22.3.2.7.1. Marketing Strategies
22.3.2.7.2. Channel Strategies
22.3.3. BMC Medical Co. Ltd
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials
22.3.3.4. SWOT Analysis
22.3.3.5. Sales Footprint
22.3.3.6. Key developments
22.3.3.7. Strategy Overview
22.3.3.7.1. Marketing Strategies
22.3.3.7.2. Channel Strategies
22.3.4. Breas Medical AB
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials
22.3.4.4. SWOT Analysis
22.3.4.5. Sales Footprint
22.3.4.6. Key developments
22.3.4.7. Strategy Overview
22.3.4.7.1. Marketing Strategies
22.3.4.7.2. Channel Strategies
22.3.5. Compumedics Limited
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials
22.3.5.4. SWOT Analysis
22.3.5.5. Sales Footprint
22.3.5.6. Key developments
22.3.5.7. Strategy Overview
22.3.5.7.1. Marketing Strategies
22.3.5.7.2. Channel Strategies
22.3.6. Drive DeVilbiss Healthcare
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials
22.3.6.4. SWOT Analysis
22.3.6.5. Sales Footprint
22.3.6.6. Key developments
22.3.6.7. Strategy Overview
22.3.6.7.1. Marketing Strategies
22.3.6.7.2. Channel Strategies
22.3.7. Elmaslar Group
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials
22.3.7.4. SWOT Analysis
22.3.7.5. Sales Footprint
22.3.7.6. Key developments
22.3.7.7. Strategy Overview
22.3.7.7.1. Marketing Strategies
22.3.7.7.2. Channel Strategies
22.3.8. Fisher & Paykel Healthcare Corporation Limited
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials
22.3.8.4. SWOT Analysis
22.3.8.5. Sales Footprint
22.3.8.6. Key developments
22.3.8.7. Strategy Overview
22.3.8.7.1. Marketing Strategies
22.3.8.7.2. Channel Strategies
22.3.9. Hebei Topson Medical Technology Co., Ltd.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials
22.3.9.4. SWOT Analysis
22.3.9.5. Sales Footprint
22.3.9.6. Key developments
22.3.9.7. Strategy Overview
22.3.9.7.1. Marketing Strategies
22.3.9.7.2. Channel Strategies
22.3.10. Kare Medical and Analytical Devices Ltd. Co
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials
22.3.10.4. SWOT Analysis
22.3.10.5. Sales Footprint
22.3.10.6. Key developments
22.3.10.7. Strategy Overview
22.3.10.7.1. Marketing Strategies
22.3.10.7.2. Channel Strategies
22.3.11. Koninklijke Philips N.V
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials
22.3.11.4. SWOT Analysis
22.3.11.5. Sales Footprint
22.3.11.6. Key developments
22.3.11.7. Strategy Overview
22.3.11.7.1. Marketing Strategies
22.3.11.7.2. Channel Strategies
22.3.12. Lowenstein Medical Technology GmbH
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials
22.3.12.4. SWOT Analysis
22.3.12.5. Sales Footprint
22.3.12.6. Key developments
22.3.12.7. Strategy Overview
22.3.12.7.1. Marketing Strategies
22.3.12.7.2. Channel Strategies
22.3.13. Narang Medical Limited
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Key Financials
22.3.13.4. SWOT Analysis
22.3.13.5. Sales Footprint
22.3.13.6. Key developments
22.3.13.7. Strategy Overview
22.3.13.7.1. Marketing Strategies
22.3.13.7.2. Channel Strategies
22.3.14. SoMillionetics International, Inc.
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. Key Financials
22.3.14.4. SWOT Analysis
22.3.14.5. Sales Footprint
22.3.14.6. Key developments
22.3.14.7. Strategy Overview
22.3.14.7.1. Marketing Strategies
22.3.14.7.2. Channel Strategies
22.3.15. Draegerwerk AG & Co. KGaA
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. Key Financials
22.3.15.4. SWOT Analysis
22.3.15.5. Sales Footprint
22.3.15.6. Key developments
22.3.15.7. Strategy Overview
22.3.15.7.1. Marketing Strategies
22.3.15.7.2. Channel Strategies
22.3.16. Apex Medical Corporation
22.3.16.1. Overview
22.3.16.2. Product Portfolio
22.3.16.3. Key Financials
22.3.16.4. SWOT Analysis
22.3.16.5. Sales Footprint
22.3.16.6. Key developments
22.3.16.7. Strategy Overview
22.3.16.7.1. Marketing Strategies
22.3.16.7.2. Channel Strategies
22.3.17. ResMed Inc.
22.3.17.1. Overview
22.3.17.2. Product Portfolio
22.3.17.3. Key Financials
22.3.17.4. SWOT Analysis
22.3.17.5. Sales Footprint
22.3.17.6. Key developments
22.3.17.7. Strategy Overview
22.3.17.7.1. Marketing Strategies
22.3.17.7.2. Channel Strategies
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Positive Air Pressure Devices Market
